Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

25.36
+0.35001.40%
Post-market: 25.860.5000+1.97%18:42 EST
Volume:962.29K
Turnover:24.72M
Market Cap:1.99B
PE:-14.04
High:26.48
Open:25.57
Low:25.24
Close:25.01
52wk High:36.26
52wk Low:2.86
Shares:78.66M
Float Shares:53.14M
Volume Ratio:0.52
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8064
EPS(LYR):-2.2041
ROE:-59.22%
ROA:-34.41%
PB:6.49
PE(LYR):-11.51

Loading ...

Olema Pharmaceuticals to Join Major Biotech and Oncology Investor Conferences

Reuters
·
Feb 05

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Feb 04

Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA) and Maze Therapeutics, Inc. (MAZE)

TIPRANKS
·
Feb 03

A Look At Olema Pharmaceuticals (OLMA) Valuation After Renewed Buy Ratings And Phase 3 Breast Cancer Plans

Simply Wall St.
·
Feb 02

Analysts Offer Insights on Healthcare Companies: Nuwellis (NUWE) and Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Feb 01

Is It Too Late To Consider Olema Pharmaceuticals (OLMA) After Its 320% One-Year Surge?

Simply Wall St.
·
Jan 31

Olema Pharmaceuticals CFO Departs; CEO Assumes Interim Role

TIPRANKS
·
Jan 31

BRIEF-Olema Oncology Announces Departure Of Chief Operating And Financial Officer

Reuters
·
Jan 31

Olema Pharmaceuticals CFO Shane Kovacs Departs

Reuters
·
Jan 31

Olema Pharmaceuticals Inc - Begins Search for New CFO; Appoints Sean P. Bohen as Interim CFO

THOMSON REUTERS
·
Jan 31

Olema Oncology Announces Departure of Chief Operating and Financial Officer

THOMSON REUTERS
·
Jan 31

Olema Pharmaceuticals Inc - Oncology Announces Departure of COO and CFO Shane Kovacs

THOMSON REUTERS
·
Jan 31

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Jan 27

Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up

TIPRANKS
·
Jan 24

Director Cyrus Harmon Reports Disposal of Olema Pharmaceuticals Inc. Common Shares

Reuters
·
Jan 22

Director Cyrus Harmon Reports Sale of Olema Pharmaceuticals Common Shares

Reuters
·
Jan 17

Olema Pharmaceuticals Chief Discovery Officer David C. Myles Reports Disposal of Common Shares

Reuters
·
Jan 15

Olema Highlights Palazestrant Strategy in New Investor Presentation

TIPRANKS
·
Jan 13

Assessing Olema Pharmaceuticals (OLMA) Valuation After Analyst Upgrades And Recent Fundraising

Simply Wall St.
·
Jan 11

Olema Pharmaceuticals Inc : UBS Initiates Coverage With Buy Rating and Target Price $45

THOMSON REUTERS
·
Jan 07